Unibest
← Back to patent-cliff list

Netupitant

Tier C — Watch / trade

Netupitant

F. Hoffmann-La Roche
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:NK1R

Indications (approved):Chemotherapy-induced nausea and vomiting, Neoplasm

Regional status

US
No progress
2011-04-01
EU
No progress
2011-04-01
China
Phase I
2016-08-23
Japan
-

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 8 · Total yield /
NETUP-0015326-23-8NETUP-00258757-38-3NETUP-003115309-58-5NETUP-00433872-80-9NETUP-005342417-04-3NETUP-006881743-64-2NETUP-007342417-01-0NETUP-008342417-02-1NETUP-009290297-25-5NETUP-010289686-69-7API · Netupitant
CodeCAS No.Intermediate
NETUP-0015326-23-86-chloronicotinic acid
NETUP-00258757-38-36-chloronicotinoyl chloride
NETUP-003115309-58-5N-(tert-butyl)-6-chloronicotinamide
NETUP-00433872-80-9o-tolylmagnesium chloride
NETUP-005342417-04-3N-(tert-butyl)-6-chloro-4-(o-tolyl)nicotinamide
NETUP-006881743-64-2N-(tert-butyl)-6-(4-methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide
NETUP-007342417-01-06-(4-methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide
NETUP-008342417-02-1methyl (6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)carbamate
NETUP-009290297-25-5N-methyl-6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-amine
NETUP-010289686-69-7Available2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoyl chloride
OptimisedRoute 2Steps 8 · Total yield 31.6 g
NETUP-0114548-45-2NETUP-01255403-34-4NETUP-01355403-35-5NETUP-014290297-21-1NETUP-015290297-22-2NETUP-01616419-60-6NETUP-017290297-23-3NETUP-018290297-24-4API · Netupitant
CodeCAS No.Intermediate
NETUP-0114548-45-22-chloro-5-nitropyridine
NETUP-01255403-34-41-methyl-4-(5-nitropyridin-2-yl)piperazine
NETUP-01355403-35-56-(4-methylpiperazin-1-yl)pyridin-3-amine
NETUP-014290297-21-1N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)pivalamide
NETUP-015290297-22-2N-(4-iodo-6-(4-methylpiperazin-1-yl)pyridin-3-yl)pivalamide
NETUP-01616419-60-6o-tolylboronic acid
NETUP-017290297-23-3N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)pivalamide
NETUP-018290297-24-46-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-amine

Frequently asked questions

What are the approved indications of Netupitant?

Approved indications include: Chemotherapy-induced nausea and vomiting, Neoplasm.

When does the Netupitant patent expire?

No public expiry year is available for Netupitant yet; this page updates once verified.

How many synthesis routes are recorded for Netupitant?

2 synthesis routes are recorded; the shortest is 8 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Netupitant intermediates?

1 intermediate CAS of Netupitant are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Netupitant intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-09